Please provide your email address to receive an email when new articles are posted on . The FDA approved a novel PET radiotracer for evaluation of possible MI and ischemia. The approval is based on ...
Figure 1. Representative whole body planar images of 99m Tc-p5+14 of healthy subjects and, with SPECT/CT images, of a patient with ATTRv cardiac amyloidosis at 1 h post injection showing no uptake in ...
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, ...
Houston Methodist Hospital and Madison, Wis.-based UW Health are the first U.S. healthcare organizations to use GE Healthcare’s new PET radiotracer, Flyrcado. The radiopharmaceutical is a positron ...
A newly developed cardiac PET imaging technique offers a simpler way to detect significant coronary artery disease—eliminating the need for complex scanning protocols. This innovative approach, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results